Home
Reels
Grupuri
Pagini
Arata mai mult
Grupuri Pagini Events Blogs Funding
Conecteaza-te Inscrie-te
Night Mode
What Are the Key Challenges Facing the AAV Vector-based Gene Therapy Market?
Despite its promise, the AAV vector-based gene therapy market faces significant challenges. High treatment costs—often exceeding millions of dollars per patient—raise access and reimbursement concerns. Payers are scrutinizing value, and outcomes-based payment models are being explored. The adeno-associated virus vector-based gene therapy market also faces immunogenicity issues....
0 Commentarii ·0 Distribuiri ·130 Views ·0 previzualizare
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!